The Medicare GLP-1 Bridge Program is a temporary program beginning July 1, 2026, that helps eligible Medicare beneficiaries access certain weight-loss GLP-1 medications for a reduced copay. To qualify, you must have a Medicare Part D or Medicare Advantage prescription drug plan and meet the program's medical criteria. Your doctor must prescribe the medication and submit a prior authorization request. Once approved, you can fill the prescription at a participating pharmacy and pay the program copay. Contact your doctor to determine whether you qualify and begin the enrollment process.
The GLP-1 Bridge program is for those who have a Part D plan but this program doesn’t actually count towards your Part D coverage speak with your doctor to get the prior authorization and, if you qualify, be sure that the pharmacy bills the Bridge program (not your Part D drug plan).
The Medicare GLP-1 Bridge Program is designed to help eligible beneficiaries maintain access to certain GLP-1 medications during coverage transitions. Availability and eligibility vary by plan and medication. To enroll, contact your Medicare plan directly or speak with a licensed Medicare agent who can help determine whether you qualify and explain your options.
You do not enroll yourself in the Medicare GLP‑1 Bridge program — your doctor submits a prior authorization and prescription to CMS’s central pocessing center and you meet the requirements bmi requirements
The Medicare GLP-1 Bridge is a temporary, short-term demonstration program starting July 1, 2026, designed to help Medicare beneficiaries access specific weight-loss medications that are not typically covered by standard Part D plans.
You do not enroll yourself in the Medicare GLP‑1 Bridge program — your doctor submits a prior authorization and prescription to CMS’s central processor (Humana), and once approved, you fill your prescription using the Bridge BIN 028918 and PCN MEDDGLP1BR.
The Medicare GLP-1 Bridge is a temporary program that starts July 1, 2026 and runs through December 31, 2027 and gives eligible Medicare Part D beneficiaries access to certain GLP-1 drugs for $50 a month regardless of dosage. The claims are handled directly through CMS and to enroll, you simply need to meet certain criteria such as BMI metrics and be prescribed by your doctor.
